AR003114A1 - Uso de polisacaridos sulfatados para la preparacion de un medicamento para la inhibicion de infeccion de rotavirus y composicion que los contienen - Google Patents

Uso de polisacaridos sulfatados para la preparacion de un medicamento para la inhibicion de infeccion de rotavirus y composicion que los contienen

Info

Publication number
AR003114A1
AR003114A1 ARP960101962A AR10196296A AR003114A1 AR 003114 A1 AR003114 A1 AR 003114A1 AR P960101962 A ARP960101962 A AR P960101962A AR 10196296 A AR10196296 A AR 10196296A AR 003114 A1 AR003114 A1 AR 003114A1
Authority
AR
Argentina
Prior art keywords
preparation
composition containing
rotavirus infection
inhibition
medicinal product
Prior art date
Application number
ARP960101962A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR003114A1 publication Critical patent/AR003114A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se provee un uso de polisacáridos sulfatados para la preparación de un medicamento para inhibir la infección de rotavirus de células humanos, tratandoel rotavirus con un polisacárido sulfatado. Los polisacáridos sulfatados inclyen carragenina y sulfato de dextrano. El agente más eficaz para inhibir lainfección causada por rotavirus celular es lambda-carragenina que puede formularse en un líquido y puede ingerirse en forma entérica. Una composiciónque contiene lambda-carragenina es un aspecto de la invención.
ARP960101962A 1995-03-29 1996-03-28 Uso de polisacaridos sulfatados para la preparacion de un medicamento para la inhibicion de infeccion de rotavirus y composicion que los contienen AR003114A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/412,808 US5658893A (en) 1995-03-29 1995-03-29 Method for inhibition of rotavirus infection with carrageenan

Publications (1)

Publication Number Publication Date
AR003114A1 true AR003114A1 (es) 1998-07-08

Family

ID=23634576

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101962A AR003114A1 (es) 1995-03-29 1996-03-28 Uso de polisacaridos sulfatados para la preparacion de un medicamento para la inhibicion de infeccion de rotavirus y composicion que los contienen

Country Status (6)

Country Link
US (1) US5658893A (es)
AR (1) AR003114A1 (es)
AU (1) AU5258196A (es)
IL (1) IL117507A0 (es)
TW (1) TW408017B (es)
WO (1) WO1996030027A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1011680C2 (nl) 1999-03-26 2000-09-27 Nutricia Nv Voedingssamenstellen die licht negatief geladen, niet-verteerbare polysacchariden bevatten en gebruik ervan voor het verminderen van transport door tight junctions.
US20040009953A1 (en) * 2002-01-10 2004-01-15 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
US8367098B2 (en) * 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
US20040191295A1 (en) * 2003-03-28 2004-09-30 Locniskar Mary Frances Composition and method for viral inhibition
US20050009782A1 (en) * 2003-07-09 2005-01-13 Comper Wayne D. Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
US20080268022A1 (en) * 2007-02-23 2008-10-30 Mccabe R Tyler Mehtods for treating and preventing ailments caused by human papillomavirus
CN101784272B (zh) 2007-08-24 2014-03-12 玛丽诺姆德生物技术公司 包含硫酸多糖的抗病毒组合物
KR101995376B1 (ko) * 2018-08-20 2019-07-02 한미약품 주식회사 카라기난을 유효성분으로 포함하는 항-바이러스 조성물
EP3939597A1 (en) 2020-07-16 2022-01-19 Marinomed Biotech AG Antiviral pharmaceutical composition comprising a carrageenan component
CN115089600B (zh) * 2022-06-28 2023-08-04 广东医科大学 麦冬皂苷d在制备抗轮状病毒药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
EP0293826A3 (en) * 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
GB2262531B (en) * 1991-12-17 1995-12-06 Erba Carlo Spa Antiviral sulphated polysaccharides
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
JPH08506570A (ja) * 1993-01-08 1996-07-16 ザ ポピュレーション カウンシル 性行為感染症予防のための硫酸化多糖類の使用

Also Published As

Publication number Publication date
TW408017B (en) 2000-10-11
WO1996030027A1 (en) 1996-10-03
AU5258196A (en) 1996-10-16
IL117507A0 (en) 1996-07-23
US5658893A (en) 1997-08-19

Similar Documents

Publication Publication Date Title
AR003114A1 (es) Uso de polisacaridos sulfatados para la preparacion de un medicamento para la inhibicion de infeccion de rotavirus y composicion que los contienen
AR020051A1 (es) Procedimiento de uso y uso de una combinacion de un anticuerpo anti-erbb2 y un agente quimicoterapeutico distinto de un derivado de antraciclina para la manufactura de un medicamento util para el tratamiento de cancer
AR005679A1 (es) Composiciones suavizantes de la piel que contienen hidroxiacidos y metodos para su utilizacion.
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR020019A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de cancer de mama
TW224428B (es)
BR9406893A (pt) Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids
BR9910251A (pt) Estimulação hematopoiética
ES2183186T3 (es) Composiciones cosmeticas en polvo que contienen elastomeros de silicona.
ES2094781T3 (es) Composicion farmaceutica de microparticulas con liberacion controlada y su proceso de preparacion.
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
IT8921086A0 (it) Protesi vascolare contenente nella parete microcapsule inglobanti cellule produttrici di ormoni.
MX9201782A (es) Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
ES2074698T3 (es) Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
AU7023987A (en) Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
BR0014355A (pt) Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva
IS5359A (is) Lyfjasamsetning með D-vítamíni og kalsíum, framleiðsla þeirra og notkun í meðferðarskyni
EP0879597A4 (en) TRANSPARENT AQUEOUS SOLUTION OF DICLOFENAC SODIUM, MEDICINAL COMPOSITIONS, AND USES
ATE269710T1 (de) Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
ES2152272T3 (es) Uso de sulodexide y de medicamentos que lo contienen para el tratamiento de la nefropatia diabetica.
ES2110058T3 (es) Composicion de silicona dispersable en agua.